These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 8966557)
1. HIV-1 evolution and disease progression. Nowak MA; Anderson RM; Boerlijst MC; Bonhoeffer S; May RM; McMichael AJ Science; 1996 Nov; 274(5289):1008-11. PubMed ID: 8966557 [No Abstract] [Full Text] [Related]
2. AIDS pathogenesis: a finite immune response to blame? Miedema F; Klein MR Science; 1996 Apr; 272(5261):505-6. PubMed ID: 8614796 [No Abstract] [Full Text] [Related]
3. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Wolinsky SM; Korber BT; Neumann AU; Daniels M; Kunstman KJ; Whetsell AJ; Furtado MR; Cao Y; Ho DD; Safrit JT Science; 1996 Apr; 272(5261):537-42. PubMed ID: 8614801 [TBL] [Abstract][Full Text] [Related]
4. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope. Emini EA; Koff WC Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131 [No Abstract] [Full Text] [Related]
5. Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient. Brener J; Gall A; Hurst J; Batorsky R; Lavandier N; Chen F; Edwards A; Bolton C; Dsouza R; Allen T; Pybus OG; Kellam P; Matthews PC; Goulder PJR Retrovirology; 2018 Jan; 15(1):7. PubMed ID: 29338738 [TBL] [Abstract][Full Text] [Related]
6. Immune clearance of HIV type 1 replication-active cells: a model of two patterns of steady state HIV infection. Bucy RP AIDS Res Hum Retroviruses; 1999 Feb; 15(3):223-7. PubMed ID: 10052752 [No Abstract] [Full Text] [Related]
7. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual. Harrer T; Harrer E; Barbosa P; Kaufmann F; Wagner R; Brüggemann S; Kalden JR; Feinberg M; Johnson RP; Buchbinder S; Walker BD J Immunol; 1998 Nov; 161(9):4875-81. PubMed ID: 9794421 [TBL] [Abstract][Full Text] [Related]
8. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. Musey L; Hughes J; Schacker T; Shea T; Corey L; McElrath MJ N Engl J Med; 1997 Oct; 337(18):1267-74. PubMed ID: 9345075 [TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors. Betts MR; Krowka JF; Kepler TB; Davidian M; Christopherson C; Kwok S; Louie L; Eron J; Sheppard H; Frelinger JA AIDS Res Hum Retroviruses; 1999 Sep; 15(13):1219-28. PubMed ID: 10480635 [TBL] [Abstract][Full Text] [Related]
11. A long-term follow-up of an HIV type 1-infected patient reveals a coincidence of Nef-directed cytotoxic T lymphocyte effectors and high incidence of epitope-deleted variants. Singh MK; Janvier G; Calvez V; Coulaud P; Rivière Y AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1265-71. PubMed ID: 11559426 [TBL] [Abstract][Full Text] [Related]
12. Apoptosis of CD4+ and CD19+ cells during human immunodeficiency virus type 1 infection--correlation with clinical progression, viral load, and loss of humoral immunity. Samuelsson A; Broström C; van Dijk N; Sönnerborg A; Chiodi F Virology; 1997 Nov; 238(2):180-8. PubMed ID: 9400591 [TBL] [Abstract][Full Text] [Related]
13. Longitudinal study of HIV-specific cytotoxic lymphocytes in HIV type 1-infected patients: relative balance between host immune response and the spread of HIV type 1 infection. Bariou C; Genetet N; Ruffault A; Michelet C; Cartier F; Genetet B AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1301-12. PubMed ID: 9339847 [TBL] [Abstract][Full Text] [Related]
14. Loss of HIV-1-specific immunity during treatment interruption in 2 chronically infected patients. Blankson JN; Gallant JE; Quinn TC; Bartlett JG; Siliciano RF JAMA; 2002 Jul; 288(2):162-4. PubMed ID: 12095377 [No Abstract] [Full Text] [Related]
15. CD8+ cells in human immunodeficiency virus type I pathogenesis: cytolytic and noncytolytic inhibition of viral replication. Yang OO; Walker BD Adv Immunol; 1997; 66():273-311. PubMed ID: 9328644 [No Abstract] [Full Text] [Related]
16. Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses. Salgado M; Garcia-Minambres A; Dalmau J; Jiménez-Moyano E; Viciana P; Alejos B; Clotet B; Prado JG; Martinez-Picado J J Virol; 2018 Jun; 92(12):. PubMed ID: 29593044 [TBL] [Abstract][Full Text] [Related]
17. The influence of antigenic variation on cytotoxic T lymphocyte responses in HIV-1 infection. Price DA; Meier UC; Klenerman P; Purbhoo MA; Phillips RE; Sewell AK J Mol Med (Berl); 1998 Sep; 76(10):699-708. PubMed ID: 9766848 [TBL] [Abstract][Full Text] [Related]
18. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection. Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209 [TBL] [Abstract][Full Text] [Related]
19. Cytotoxic-T-cell responses in early HIV-1 infection. Phillips AN N Engl J Med; 1998 Feb; 338(9):622-3. PubMed ID: 9480442 [No Abstract] [Full Text] [Related]
20. Anti-HIV type 1 memory cytotoxic T lymphocyte responses associated with changes in CD4+ T cell numbers in progression of HIV type 1 infection. Rinaldo CR; Gupta P; Huang XL; Fan Z; Mullins JI; Gange S; Farzadegan H; Shankarappa R; Muñoz A; Margolick JB AIDS Res Hum Retroviruses; 1998 Nov; 14(16):1423-33. PubMed ID: 9824320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]